Barbara Viginier

Barbara Viginier

Auto-generated profile, based on publicly available information

Barbara Viginier

IVPC UMR754, EPHE, Université PSL, INRAE, Université Claude Bernard Lyon 1, F-69007, Lyon, France

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2024 in Eurosurveillance
Verified
Journal Article
Open access
BVBarbara Viginier
Barbara Viginier
RKRaphaëlle Klitting
Raphaëlle Klitting
CGClémence Galon
Clémence Galon
VBViolaine Bonnefoux
Violaine Bonnefoux
CBChristophe Bellet
Christophe Bellet
VRVincent Raquin
Vincent Raquin
While locally-acquired dengue virus (DENV) human infections occur in mainland France since 2010, data to identify the mosquito species involved and to trace the virus are frequently lacking. Supported by a local network gathering public health agencies and research laboratories, we analysed, in late summer 2023, mosquitoes from privately-owned traps within a French urban neighbourhood affected by a dengue cluster. The cluster, in Auvergne-Rhône-Alpes, comprised three cases, including two autochthonous ones. Upon return from a recent visit to the French Caribbean Islands, the third case had consulted healthcare because of dengue-compatible symptoms, but dengue had not been recognised. For the two autochthonous cases, DENV-specific antibodies in serum or a positive quantitative PCR for DENV confirmed DENV infection. The third case had anti-flavivirus IgMs. No DENV genetic sequences were obtained from affected individuals but Aedes albopictus mosquitoes trapped less than 200 m from the autochthonous cases’ residence contained DENV. Genetic data from the mosquito-derived DENV linked the cluster to the 2023–2024 dengue outbreak in the French Caribbean Islands. This study highlights the importance of raising mosquito-borne disease awareness among healthcare professionals. It demonstrates Ae. albopictus as a DENV vector in mainland France and the value of private mosquito traps for entomo−virological surveillance.

7 November 2022 in medRxiv
Verified
Preprint
Open access
PDF file
BVBarbara Viginier
Barbara Viginier
LCLucie Cappuccio
Lucie Cappuccio
CGCéline Garnier
Céline Garnier
EMEdwige Martin
Edwige Martin
CMCarine Maisse
Carine Maisse
VRVincent Raquin
Vincent Raquin
Arbovirus emergence and epidemic potential, as approximated by the vectorial capacity formula, depends on several host and vector parameters including vector intrinsic ability to transmit the pathogen. Such ability, called vector competence is influenced by biotic (e.g. virus and vector genotype) and abiotic (e.g. temperature). Vector competence is often evaluated as a qualitative phenotype although it is a multistep, time-dependent, quantitative phenotype. Combination of experimental and modelling approaches can i) capture intra-vector dynamics of arboviral infection and ii) use data to estimate arbovirus epidemic potential. Here, we measured individual Aedes albopictus (Lyon, France) mosquitoes infection, dissemination, and transmission rate upon oral exposure to chikungunya virus (CHIKV, La Reunion Island isolate) at eleven time-points from day 2 to day 20 post-exposure (dpe) for a range of CHIKV infectious doses spanning human viremia. Statistical modelisation indicates an explosive CHIKV intra-vector dynamics mainly due to an absence of dissemination barrier with 100% of the infected mosquitoes ultimately exhibiting a disseminated infection regardless of the viral dose. Transmission rate data revealed a time and dose-dependent but overall weak transmission barrier with individuals transmitting as soon as 2 dpe and >50% infectious mosquitoes at 6 dpe for the highest dose. Epidemiological simulations conducted with an Agent-Based Model based on experimental intra-vector dynamics data showed that even at low mosquito biting rates, CHIKV triggers explosive outbreaks. Together, this reveals the high epidemic potential of this CHIKV isolate with this French metropolitan population of Aedes albopictus.

23 June 2025 in mLife
Verified
Journal Article
Open access
EMEdwige Martin
Edwige Martin
ACAn‐Nah Chanfi
An‐Nah Chanfi
BVBarbara Viginier
Barbara Viginier
VRVincent Raquin
Vincent Raquin
CVClaire Valiente-Moro
Claire Valiente-Moro
Guillaume MinardGuillaume Minard
Guillaume Minard
Impact statement: The Asian tiger mosquito, Aedes albopictus, is an invasive species that spreads diseases like chikungunya and has caused outbreaks worldwide. Studies show that mosquito‐associated microbes can affect disease transmission. One of those microbes, the parasite Ascogregarina taiwanensis, is common in native and settled mosquito populations (>3 years after introduction) but rare in recently introduced ones. We found that this parasite slows down the spread of the chikungunya virus within the mosquito and decreases its transmission rate by half. Unparasitized mosquitoes spread the virus more easily, suggesting that changes in mosquito‐associated microbes could impact disease outbreaks and public health.

5 August 2026 in Research Square
Verified
Preprint
Open access
PDF file
DBDaphné Baudon
Daphné Baudon
BVBarbara Viginier
Barbara Viginier
LLLéa Loisel
Léa Loisel
MCMarie-Pierre Confort
Marie-Pierre Confort
PEPauline Ezanno
Pauline Ezanno
VRVincent Raquin
Vincent Raquin
Rift Valley Fever Virus (RVFV) is an arbovirus responsible for significant mortality and morbidity in both humans and animals. Classified by the WHO as a priority pathogen, RVFV is at risk of worldwide emergence notably due to a large vector species spectrum. As other arboviruses, RVFV vector competence (VC) is driven by genetic and environmental factors. Understand how these factors shape RVFV transmission by mosquitoes is therefore critical to mitigate Rift Valley fever emergence and spread. Conversely to dengue, chikungunya or Zika viruses, little is known on the impact of major VC drivers such as mosquitoes species or virus dose for RVFV. In addition, some potential VC drivers have been overlooked for most arboviruses, such as the cellular origin of viruses used in VC assays. Finally, intra-vector infection dynamics (DIV), represented by the distribution of extrinsic incubation period (EIP) within the mosquito population, remains a black box for many vector-arbovirus pairs. Here, we solved some of these gaps by feeding Aedes aegypti and Culex quinquefasciatus mosquitoes with the RVFV ZH548 reference strain prior to detect, at various time post RVFV exposure, infectious virus in mosquito tissues representative of infection, dissemination and transmission stages. These data were then used to model RVFV DIV for both mosquito species. Major VC variations were observed according to mosquito species, virus dose and cell line used for virus stock production, in a stage-specific manner. Furthermore, key differences were unveiled between the DIV of Ae. aegypti and Cx . quinquefasciatus mosquitoes. This study highlights the pattern of RVFV dynamics in mosquitoes according to major VC drivers, and provides a reference data set upon standardized experimental VC assay in two major RVFV vector genera ( Aedes and Culex ). Altogether, this work opens new avenues towards the understanding RVFV-mosquito interactions, and how they can modulate RVFV emergence and spread. AUTHOR SUMMARY Rift valley fever virus (RVFV) is an understudied but threatening mosquito-borne pathogen, both from human and animal health perspective. The limited number of studies, notably on mosquito capacity to transmit this virus (vector competence), prevents us to fully understand RVFV epidemiology and mitigate emergence. Here, I explored key aspects of RVFV transmission by exposing mosquitoes to a reference virus strain through an artificial blood meal. Results show that the mosquito species, the dose of virus in the blood meal or the way the virus is prepared prior to add it into the blood meal impact vector competence. Each factor above displays stage-specific impact on RVFV-mosquito interaction, modulating either initial mosquito infection, virus dissemination within the mosquito cavity or virus spread in vector’s saliva. Finally, modeling tools applied to vector competence data showed that each mosquito species present a specific balance between susceptibility (% of mosquitoes infected) and time to infectiousness (median number of days to switch from infected to disseminated stage). Altogether, this work uncovers key features of mosquito vector competence for RVFV, explains previous literature discrepancies and highlights the benefit of combining experimental and modeling work to link vector competence and epidemiological studies.